Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells
Open accessAbstract
Background: Spontaneous interleukin-6 (IL-6) production has been observed in various tumors and implicated in the pathogenesis, progression and drug resistance in cancer. However, the regulation of IL-6 autocrine production in cancer cells is not fully understood. IL-6 is auto-regulated in many types of cell. Two of the three major downstream pathways of IL-6, MEK/extracellular signal-related kinase (Erk) pathway and phosphatidylinositol 3-kinase (PI3-K)/Akt pathway, have been shown to regulate IL-6 expression through the activation of AP-1 and NF-κB. However, it is not clear what the role of Janus kinase (Jak) 2/signal transducer and activator of transcription (Stat) 3 pathway. This study was designed to determine the role of Jak2/Stat3 pathway in the regulation of IL-6 autocrine production in cancer cells. Results: Inhibitors of Jak2/Stat3, MEK/Erk and PI3-K/Akt pathways down-regulated IL-6 secretion in the lung adenocarcinoma PC14PE6/AS2 (AS2) cells, which spontaneously secreted IL-6 and possessed constitutively activated Stat3. Transfection with dominant-negative Stat3, Stat3 siRNA, or Stat3 shRNA decreased IL-6 expression in AS2 cells. Conversely, transfection with constitutively-activated Stat3 increased the production of IL-6. In AS2 derived cells, resistance to paclitaxel was positively correlated with Stat3 activation status and the expression of IL-6, which is commonly secreted in drug resistant cancer cells. The pharmacological inhibition of NF-κB, PI3-K/Akt and MEK/Erk and the pharmacological inhibition and genetic inhibition (Stat3 siRNA) of Jak2/Stat3 pathway decreased IL-6 autocrine production in various drug resistant cancer cell lines and similarly decreased IL-6 autocrine production in clinically isolated lung cancer cells. Conclusions: This study is the first to directly address the role Stat3 plays on the autocrine production of IL-6, which occurs through a positive-feedback loop. Our biochemical and genetic studies clearly demonstrated that Jak2/Stat3, in combination with other IL-6 downstream pathways, contributed frequently and substantially to IL-6 autocrine production in a broad spectrum of cancer cell lines as well as in clinical cancer samples. Our findings suggest that Stat3 could potentially be regulated to suppress IL-6 autocrine production in cancer cells to inhibit the progression of cancer and reduce drug resistance.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
STAT3 activation potentiates IL-6 signaling by increasing receptor and ligand levels.
“STAT3 activation potentiates IL-6 signaling by increasing receptor and ligand levels”
From Dynamic IL-6R/STAT3 signaling leads to heterogeneity of metabolic phenotype in pancreatic ductal adenocarcinoma cells (2024) · cites this paper as [38]
The Discussion (page unavailable) reports that STAT3 contributes to IL-6 autocrine production in the cancer cells tested, supporting increased ligand production. The Background identifies the IL-6 receptor subunits gp80 and gp130, but the cited passages do not show that STAT3 increases receptor levels. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,295 · see citing works
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201 · see citing works
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790 · see citing works
Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Förster, I., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80005-9 · Cited by 1,220 · see citing works
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
Wang, T., Niu, G., Kortylewski, M., Burdelya, L. G., Shain, K. H., Zhang, S., Bhattacharya, R., Gabrilovich, D. I., Heller, R. F., Coppola, D., et al. (2003) · Nature Medicine · doi:10.1038/nm976 · Cited by 1,159 · see citing works
Interleukin-6: from basic science to medicine--40 years in immunology.
Kishimoto, T. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115806 · Cited by 1,083 · see citing works
Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T., & Akira, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10193 · Cited by 959 · see citing works
Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells
Sullivan, N. J., Sasser, A. K., Axel, A. E., Vesuna, F., Raman, V, Ramirez, N., Oberyszyn, T. M., & Hall, B. M. (2009) · Oncogene · doi:10.1038/onc.2009.180 · Cited by 757 · see citing works
The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells
Sumimoto, H., Imabayashi, F., Iwata, T., & Kawakami, Y. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051848 · Cited by 696 · see citing works
IL-6 signal transduction and its physiological roles: the signal orchestration model
Kamimura, D., Ishihara, K., & Hirano, T. (2003) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0012-2 · Cited by 673 · see citing works
Gao, S. P., Mark, K. G., Leslie, K., Pao, W., Motoi, N., Gerald, W. L., Travis, W. D., Bornmann, W., Veach, D., Clarkson, B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31871 · Cited by 666 · see citing works
Yang, J., Liao, X., Agarwal, M. K., Barnes, L., Auron, P. E., & Stark, G. R. (2007) · Genes & Development · doi:10.1101/gad.1553707 · Cited by 611 · see citing works
Nakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiuchi, N., Kitaoka, T., Fukada, T., Hibi, M., & Hirano, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00734.x · Cited by 565 · see citing works
Ogura, H., Murakami, M., Okuyama, Y., Tsuruoka, M., Kitabayashi, C., Kanamoto, M., Nishihara, M., Iwakura, Y., & Hirano, T. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.018 · Cited by 564 · see citing works
Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation
Yang, J., Chatterjee-Kishore, M., Staugaitis, S. M., Nguyen, H., Schlessinger, K., Levy, D. E., & Stark, G. R. (2005) · Cancer Research · doi:10.1158/0008-5472.939.65.3 · Cited by 405 · see citing works
Autocrine IL-6 signaling: a key event in tumorigenesis?
Grivennikov, S., & Karin, M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.020 · Cited by 379 · see citing works
Interleukin‐6 and its receptor in cancer: Implications for Translational Therapeutics
Hong, D. S., Angelo, L. S., & Kurzrock, R. (2007) · Cancer · doi:10.1002/cncr.22999 · Cited by 370 · see citing works
Roles of unphosphorylated STATs in signaling
Yang, J., & Stark, G. R. (2008) · Cell Research · doi:10.1038/cr.2008.41 · Cited by 347 · see citing works
Dendorfer, U., Oettgen, P., & Libermann, T. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4443 · Cited by 331 · see citing works
Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.
Conze, D. B., Weiss, L., Regen, P. S., Bhushan, A., Weaver, D. L., Johnson, P. F., & Rincón, M. (2001) · PubMed · Cited by 282 · see citing works
IL-6: Insights into Novel Biological Activities
Barton, B. E. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4420 · Cited by 269 · see citing works
IL-6 involvement in epithelial cancers
Schafer, Z. T., & Brugge, J. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci34237 · Cited by 267 · see citing works
Samavati, L., Rastogi, R., Du, W., Hüttemann, M., Fite, A., & Franchi, L. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.02.018 · Cited by 255 · see citing works
Cahill, C. M., & Rogers, J. T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707692200 · Cited by 254 · see citing works
Wagoner, N. J. V., Oh, J., Repovic, P., & Benveniste, E. N. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05236.1999 · Cited by 244 · see citing works
IL-6 Induces NF-κB Activation in the Intestinal Epithelia
Wang, L., Walia, B., Evans, J., Gewirtz, A. T., Merlin, D., & Sitaraman, S. V. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3194 · Cited by 243 · see citing works
Yeh, H.-H., Lai, W.-W., Chen, H. H. W., Liu, H.-S., & Su, W.-C. (2006) · Oncogene · doi:10.1038/sj.onc.1209464 · Cited by 230 · cited 6× · see citing works
“degrees of Stat3 activation and inactivation on the mRNA expression and the secretion of IL-6 using parental AS2 cells and various previously established AS2derived cell lines with different Stat3 activation status: vector control cells, two AS2/S3C cells, two AS2/S3D cells, and two AS2/S3F cells [2,10].”
BackgroundMethodInfluentialSelf-citationRay, A., Tatter, S. B., May, L. T., & Sehgal, P. B. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6701 · Cited by 209 · see citing works
LeFloch, R., Pouysségur, J., & Lenormand, P. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00800-07 · Cited by 204 · see citing works
Kuo, C., Hsieh, H., Pan, W., Chen, C.-P., Liou, J., Lee, S., Chang, Y.-L., Chen, L., Chen, C.-T., & Chang, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3474 · Cited by 202 · see citing works
Self-citationDuan, Z., Feller, A. J., Penson, R. T., Chabner, B. A., & Seiden, M. V. (1999) · PubMed · Cited by 165 · see citing works
Essential role of STAT3 in cytokine‐driven NF‐κB‐mediated serum amyloid A gene expression
Hagihara, K., Nishikawa, T., Sugamata, Y., Song, J., Isobe, T., Taga, T., & Yoshizaki, K. (2005) · Genes to Cells · doi:10.1111/j.1365-2443.2005.00900.x · Cited by 162 · see citing works
Interleukin-6-Specific Activation of the C/EBPδ Gene in Hepatocytes Is Mediated by Stat3 and Sp1
Cantwell, C. A., Sterneck, E., & Johnson, P. F. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2108 · Cited by 162 · see citing works
Tang, C., Lu, D.-Y., Yang, R., Tsai, H.-Y., Kao, M., Fu, W., & Chen, Y. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.1292 · Cited by 160 · see citing works
Li, Y., Du, H., Qin, Y., Roberts, J., Cummings, O. W., & Yan, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0647 · Cited by 143 · see citing works
Plaisance, S., Berghe, W. V., Boone, E., Fiers, W., & Haegeman, G. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3733 · Cited by 139 · see citing works
Judd, L. M., Bredin, K., Kalantzis, A., Jenkins, B. J., Ernst, M., & Giraud, A. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.018 · Cited by 127 · see citing works
Nishikawa, T., Hagihara, K., Serada, S., Isobe, T., Matsumura, A., Song, J., Tanaka, T., Kawase, I., Naka, T., & Yoshizaki, K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3492 · Cited by 119 · see citing works
Niehof, M., Streetz, K., Rakemann, T., Bischoff, S., Manns, M., Horn, F., & Trautwein, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009284200 · Cited by 114 · see citing works
Dalwadi, H. N., Krysan, K., Heuzé‐Vourc'h, N., Dohadwala, M., Elashoff, D. A., Sharma, S. P., Cacalano, N. A., Lichtenstein, A. K., & Dubinett, S. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1205 · Cited by 107 · see citing works
Williams, L. M., Sarma, U., Willets, K., Smallie, T., Brennan, F. M., & Foxwell, B. M. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609101200 · Cited by 94 · see citing works
Tang, C., Chuang, J., Fong, Y., Maa, M. C., Way, T., & Hung, C. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn045 · Cited by 93 · see citing works
Kojima, H., Nakajima, K., & Hirano, T. (1996) · PubMed · Cited by 81 · see citing works
Interleukin 6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells.
Franchimont, N., Rydziel, S., & CANALIS, E. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119707 · Cited by 61 · see citing works
Numata, A., Shimoda, K., Kamezaki, K., Haro, T., Kakumitsu, H., Shide, K., Kato, K., Miyamoto, T., Yamashita, Y., Oshima, Y., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408442200 · Cited by 56 · see citing works
Beurel, E., & Jope, R. S. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.02.019 · Cited by 54 · see citing works
STAT3 and MITF cooperatively induce cellular transformation through upregulation of c-fos expression
Joo, A., Aburatani, H., Morii, E., Iba, H., & Yoshimura, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207174 · Cited by 48 · see citing works
Ginsberg, M. D., Czeko, E., Müller, P., Ren, Z. J., Chen, X., & Darnell, J. E., Jr. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00613-07 · Cited by 45 · see citing works
Mynard, V., Latchoumanin, O., Guignat, L., Leclerc, J., BERTAGNA, X. Y., Barré, B., Fagart, J., Coqueret, O., & CATELLI, M. G. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0417 · Cited by 43 · see citing works
Su, H.-W., Yeh, H.-H., Wang, S.-W., Shen, M.-R., Chen, T.-L., Kiela, P. R., Ghishan, F. K., & Tang, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606754200 · Cited by 42 · see citing works
Self-citationKwak, H. B., Sun, H. M., Ha, H., Lee, J.-H., Kim, H. N., & Lee, Z. H. (2008) · Molecules and Cells · doi:10.1016/s1016-8478(23)14019-2 · Cited by 31 · see citing works
Yen, C., Liang, S.-C., Jong, Y.-J., Chen, Y.-J., Lin, C.-H., Chen, Y.-M., Wu, Y., Su, W., Huang, C. F., Tseng, S.-W., et al. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.04.007 · Cited by 27 · see citing works
Self-citationDual inhibition of topoisomerase I and tubulin polymerization by BPR0Y007, a novel cytotoxic agent
Chang, J., Hsieh, H., Pan, W., Liou, J., Bey, S.-J., Chen, L., Liu, J.-F., & Song, J. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00197-7 · Cited by 26 · see citing works
Self-citationCheng, T., & Chang, W. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-547-3_13 · Cited by 24 · see citing works
Self-citationSTAT3-decoy ODN inhibits cytokine autocrine of murine tumor cells.
Liu, X., Li, J., & Zhang, J. (2007) · PubMed · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Shabbir, A., Cox, A., Rodriguez-Menocal, L., Salgado, M., & Badiavas, E. V. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0316 · Cited by 721 · see citing works
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
Taniguchi, K., & Karin, M. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.001 · Cited by 713 · see citing works
The Exosome ‐ A Naturally Secreted Nanoparticle and its Application to Wound Healing
Rani, S., & Ritter, T. (2015) · Advanced Materials · doi:10.1002/adma.201504009 · Cited by 295 · see citing works
MSC-exosome: A novel cell-free therapy for cutaneous regeneration
Wu, P., Zhang, B., Shi, H., Qian, H., & Xu, W. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2017.11.002 · Cited by 292 · see citing works
Chronic Obstructive Pulmonary Disease and Lung Cancer: New Molecular Insights
Adcock, I. M., Caramori, G., & Barnes, P. J. (2011) · Respiration · doi:10.1159/000324601 · Cited by 257 · see citing works
Sun, Y., Li, Q., Gui, H., Xu, D.-P., Yang, Y., Su, D., & Liu, X. (2013) · Cell Research · doi:10.1038/cr.2013.116 · Cited by 253 · see citing works
Lechner, M. G., Megiel, C., Russell, S. M., Bingham, B., Arger, N., Woo, T. T., & Epstein, A. L. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-90 · Cited by 208 · see citing works
Exosome-loaded hydrogels: A new cell-free therapeutic approach for skin regeneration
Safari, B., Aghazadeh, M., Davaran, S., & Roshangar, L. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.11.002 · Cited by 151 · see citing works
Jin, X., Yin, J., Kim, S.-H., Sohn, Y.-W., Beck, S. J., Lim, Y. C., Nam, D., Choi, Y.-J., & Kim, H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1330 · Cited by 149 · see citing works
The role of inflammation in the pathogenesis of lung cancer
Cho, W. C. S., Kwan, C. K., Yau, S., So, P. P., Poon, P. C. M., & Au, J. S. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.599801 · Cited by 139 · see citing works
Chang, C. K., Huang, C., Ma, T., Bian, E., He, Y., Zhang, L., & Li, J. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2013.12.023 · Cited by 121 · see citing works
MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression
Fan, Z., Cui, H., Yu, H., Ji, Q., Kang, L., Han, B., Wang, J., Dong, Q., Li, Y., Yan, Z., et al. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.1 · Cited by 93 · see citing works
Huang, Y.-H., Yang, P., Chuah, Q.-Y., Lee, Y., Hsieh, Y.-F., Peng, C.-W., & Chiu, S.-J. (2014) · Autophagy · doi:10.4161/auto.28772 · Cited by 82 · see citing works
Therapeutic Implication of SOCS1 Modulation in the Treatment of Autoimmunity and Cancer
Sharma, J., & Larkin, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00324 · Cited by 75 · see citing works
Yu, Y.-C., Yang, P., Chuah, Q.-Y., Huang, Y.-H., Peng, C.-W., Lee, Y., & Chiu, S.-J. (2013) · Scientific Reports · doi:10.1038/srep01675 · Cited by 71 · see citing works
Selvendiran, K., Ahmed, S., Dayton, A., Kuppusamy, M. L., Rivera, B. K., Kálai, T., Hideg, K., & Kuppusamy, P. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.9.17713 · Cited by 68 · see citing works
Deguelin Action Involves c-Met and EGFR Signaling Pathways in Triple Negative Breast Cancer Cells
Mehta, R. R., Katta, H., Alimirah, F., Patel, R., Murillo, G., Peng, X., Muzzio, M., & Mehta, R. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065113 · Cited by 67 · see citing works
Interleukin-6 Cytokine: A Multifunctional Glycoprotein for Cancer
Zarogoulidis, P. (2013) · Immunome Research · doi:10.4172/1745-7580.1000062 · Cited by 64 · see citing works
Yu, P. Y., Jin, H. W., Zhang, J.-Y., Wang, G.-F., Li, J.-R., Zhu, Z., Tian, Y., Wu, S., Xu, W., Zhang, J., et al. (2011) · Inflammation · doi:10.1007/s10753-011-9400-y · Cited by 63 · see citing works
Jung, B., Wang, X., Yi, N., Ma, J., Turner, J., & Samten, B. (2017) · Scientific Reports · doi:10.1038/srep40984 · Cited by 60 · see citing works
Shiraiwa, K., Matsuse, M., Nakazawa, Y., Ogi, T., Suzuki, K., Saenko, V., Xu, S., Umezawa, K., Yamashita, S., Tsukamoto, K., et al. (2019) · Thyroid · doi:10.1089/thy.2018.0212 · Cited by 57 · see citing works
Chen, C., Chu, C., Liu, K., Huang, C. F., Chang, J., Pan, W., Chen, H.-H., Cheng, Y.-H., Lee, K., Chen, M., et al. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.025 · Cited by 55 · see citing works
Self-citationTakada, K., Okamoto, T., Tominaga, M., Teraishi, K., Akamine, T., Takamori, S., Katsura, M., Toyokawa, G., Shoji, F., Okamoto, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181598 · Cited by 48 · see citing works
Guerra, B., Gómez‐Cabrera, M. C., Ponce‐González, J. G., Martinez-Bello, V. E., Guadalupe‐Grau, A., Santana, A., Sebastiá, V., Viña, J., & Calbet, J. A. L. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00091.2011 · Cited by 46 · see citing works
Beldi‐Ferchiou, A., Skouri, N., Ali, C. B., Safra, I., Abdelkefi, A., Ladeb, S., Mrad, K., Othman, T. B., & Ahmed, M. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174835 · Cited by 42 · see citing works
TRAIL receptors promote constitutive and inducible IL-8 secretion in non-small cell lung carcinoma
Favaro, F., Luciano‐Mateo, F., Moreno‐Càceres, J., Hernández-Madrigal, M., Both, D., Montironi, C., Püschel, F., Nadal, E., Eldering, E., & Muñoz‐Pinedo, C. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05495-0 · Cited by 41 · see citing works
JAK2/STAT3 Inhibition Attenuates Noise-Induced Hearing Loss
Wilson, T., Omelchenko, I., Foster, S., Zhang, Y., Shi, X., & Nuttall, A. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108276 · Cited by 40 · see citing works
Hsiao, Y.-C., Yeh, M., Chen, Y., Liu, J., Tang, C., & Huang, W. (2015) · Oncotarget · doi:10.18632/oncotarget.5700 · Cited by 39 · see citing works
Self-citationLiu, Y., Sun, Y., Zhou, Y., Tang, X., Wang, K., Ren, Y. T., & He, J. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106025 · Cited by 38 · see citing works
Zhang, Q., Yan, Y., Lv, Q., Li, Y., Wang, R., Sun, G., Li, P., Hu, J., Xie, N., Zhang, C. M., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04021-y · Cited by 37 · see citing works
Chronic Stress Mediates Inflammatory Cytokines Alterations and Its Role in Tumorigenesis
Liu, Z., Meng, L., & Bai, Y. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s485159 · Cited by 36 · see citing works
Decreased expression and activation of Stat3 in severe preeclampsia
Zhang, Z., Yang, X., Zhang, L., Duan, Z., Jia, L., Wang, P., Shi, Y., Li, Y., & Gao, J. (2015) · Journal of Molecular Histology · doi:10.1007/s10735-015-9613-8 · Cited by 35 · see citing works
Wu, C., Ge, J., Yang, M., Yan, Q., Wang, Y., Yu, H., Yang, H., & Zou, J. (2021) · European journal of medical research · doi:10.1186/s40001-021-00555-1 · Cited by 35 · see citing works
Ono, T., Kohro, Y., Kohno, K., Tozaki‐Saitoh, H., Nakashima, Y., & Tsuda, M. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.07.025 · Cited by 34 · see citing works
Hung, C.-H., Wu, S., Yao, C.-I., Yeh, H.-H., Lin, C., Chu, C., Huang, T.-Y., Shen, M., Lin, C., & Su, W. (2024) · Nature Communications · doi:10.1038/s41467-024-51831-7 · Cited by 34 · see citing works
Self-citationLe, B., Pham, T. N. A., & Yang, S. H. (2020) · Foods · doi:10.3390/foods9121808 · Cited by 34 · see citing works
JAK2 inhibition for the treatment of hematologic and solid malignancies
Harry, B. L., Eckhardt, S. G., & Jimeno, A. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.677432 · Cited by 33 · see citing works
Icariside II Induces Apoptosis of Melanoma Cells Through the Downregulation of Survival Pathways
Wu, J., Xu, J., Eksioglu, E. A., Chen, X., Zhou, J., Fortenbery, N. R., Wei, S., & Dong, J. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2013.741745 · Cited by 32 · see citing works
Rodríguez, D., Silvera, R., Carrió, R., Nadji, M., Caso, R., Rodríguez, G., Iragavarapu‐Charyulu, V., & Torroella‐Kouri, M. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.06.008 · Cited by 32 · see citing works
Eitner, A., König, C., Kohler, F. C., Hofmann, G. O., Wildemann, B., Aurich, M. E., & Schaible, H. (2024) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2024.02.006 · Cited by 31 · see citing works
Attiq, A., & Afzal, S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1255727 · Cited by 30 · see citing works
Alshaker, H. A., Wang, Q., Frampton, A. E., Krell, J., Waxman, J., Winkler, M. H., Stebbing, J., Cooper, C., Yagüe, E., & Pchejetski, D. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3228-8 · Cited by 30 · see citing works
Vigna angularis inhibits IL-6-induced cellular signalling and ameliorates collagen-induced arthritis
Oh, H., Lee, S. W., Yun, B. R., Hwang, B. S., Kim, S. N., Park, C. S., Jeoung, S.-H., Kim, H.-K., Lee, W. S., & Rho, M. (2013) · Rheumatology · doi:10.1093/rheumatology/ket302 · Cited by 29 · see citing works
Inhibitory effects of Schisandrin�B on human prostate cancer cells
Nasser, M. I., Han, T., Adlat, S., Tian, Y., & Jiang, N. (2018) · Oncology Reports · doi:10.3892/or.2018.6791 · Cited by 28 · see citing works
Human metapneumovirus inhibits the IL-6-induced JAK/STAT3 signalling cascade in airway epithelium
Mitzel, D., Jaramillo, R. J., Stout-Delgado, H. W., Senft, A. P., & Harrod, K. S. (2013) · Journal of General Virology · doi:10.1099/vir.0.055632-0 · Cited by 26 · see citing works
Dysregulation of janus kinases and signal transducers and activators of transcription in cancer.
Costa‐Pereira, A. P., Bonito, N. A., & Seckl, M. J. (2011) · Europe PMC (PubMed Central) · Cited by 24 · see citing works
Qu, H.-M., Qu, L.-P., Li, X., & Pan, X.-Z. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.63261 · Cited by 24 · see citing works
Ling-Na, K. O. N. G., Lin, X., Huang, C., Ma, T., Meng, X., Hu, C., Wang, Q., Yan-Hui, L. I. U., Shi, Q., & Li, J. (2019) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(19)30014-7 · Cited by 24 · see citing works
Surmiak, M., Kosałka-Węgiel, J., Polański, S., & Sanak, M. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13581 · Cited by 24 · see citing works
Determinants of the extent and duration of STAT3 signaling
Groner, B. (2012) · JAK-STAT · doi:10.4161/jkst.21469 · Cited by 24 · see citing works
Zhou, J., Chong, P. S. Y., Lu, X., Cheong, L.-L., Bi, C., Liu, S.-C., Zhou, Y., Tan, T. Z., Yang, H. H., Chung, T., et al. (2014) · Experimental Hematology · doi:10.1016/j.exphem.2014.08.001 · Cited by 23 · see citing works
Identification of novel small molecules that inhibit STAT3-dependent transcription and function
Kolosenko, I., Yu, Y., Busker, S., Dyczynski, M., Liu, J., Haraldsson, M., Palm‐Apergi, C., Helleday, T., Tamm, K. P., Page, B. D. G., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178844 · Cited by 23 · see citing works
Li, H., Lee, C. K., Pang, H., Chan, H.-T., Lo, I. L., Lam, S. K., Cheong, T.-H., & Ho, J. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.10.012 · Cited by 21 · see citing works
IL-6, IL-10, c-Jun and STAT3 expression in B-CLL
Antosz, H., Wojciechowska, K., Sajewicz, J., Choroszyńska, D., Marzec‐Kotarska, B., Osiak, M., Pająk, N., Tomczak, W., Jargiełło-Baszak, M., & Baszak, J. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.11.006 · Cited by 21 · see citing works
Rehm, A., Gätjen, M., Gerlach, K., Scholz, F., Mensen, A., Gloger, M., Heinig, K., Lamprecht, B., Mathas, S., Bégay, V., et al. (2014) · Nature Communications · doi:10.1038/ncomms6057 · Cited by 21 · see citing works
The decreased expression of Stat3 and p-Stat3 in preeclampsia-like rat placenta
Zhang, Z., Wang, X., Wang, J., & Zhang, L. (2018) · Journal of Molecular Histology · doi:10.1007/s10735-018-9757-4 · Cited by 21 · see citing works
Huang, W., Huang, L., Wen, M., Fang, M., Deng, Y., & Zeng, H. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9559 · Cited by 19 · see citing works
Self-citationSignal transducers and activators of transcription 3 function in lung cancer
Li, Y.-C., Li, C.-J., Zhang, D., & Pan, J. (2013) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.119100 · Cited by 18 · see citing works
Therapy with JAK2 Inhibitors for Myeloproliferative Neoplasms
Santos, F. P. S., & Verstovšek, S. (2012) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.07.008 · Cited by 18 · see citing works
MicroRNAs-mediated regulation pathways in rheumatic diseases
Assadiasl, S., Rajabinejad, M., Soleimanifar, N., Makiyan, F., Azizi, E., Rezaiemanesh, A., & Nicknam, M. H. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01097-6 · Cited by 15 · see citing works
Edelmann, S., Wiegand, A., Hentrich, T., Pasche, S., Schulze-Hentrich, J. M., Munk, M. H. J., Fallgatter, A. J., Kreifelts, B., & Nieratschker, V. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1125553 · Cited by 15 · see citing works
Woo, S., Choi, Y. K., KIM, A.-J., Yun, Y. J., Shin, Y. C., Cho, S., & Ko, S. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4889 · Cited by 15 · see citing works
The BK Channel Limits the Pro-Inflammatory Activity of Macrophages
Chen, Y., Markov, N., Gigon, L., Hosseini, A., Yousefi, S., Stojkov, D., & Simon, H. (2024) · Cells · doi:10.3390/cells13040322 · Cited by 12 · see citing works
Blaszczak, W., White, B., Monterisi, S., & Swietach, P. (2024) · Cell Reports · doi:10.1016/j.celrep.2023.113612 · Cited by 9 · see citing works
Autocrine Regulation of Interleukin-6 via the Activation of STAT3 and Akt in Cardiac Myxoma Cells
Jougasaki, M., Takenoshita, Y., Umebashi, K., Yamamoto, M., Sudou, K., Nakashima, H., Sonoda, M., & Kinjo, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042232 · Cited by 9 · see citing works
Association of Chronic Inflammation-Associated Cancer With Cytokines
Nakase, H., & Shimomori, Y. (2025) · Cureus · doi:10.7759/cureus.92239 · Cited by 8 · see citing works
Kim, S., Kim, H., Jeong, Y., You, D., Yoon, S. Y., Lo, E., Nam, S. J., Lee, J. E., & Kim, S. W. (2023) · Biomedicines · doi:10.3390/biomedicines11030675 · Cited by 8 · see citing works
Tanabe, K. (2016) · Scientific Reports · doi:10.1038/srep25095 · Cited by 8 · see citing works
Abubaker, K., Latifi, A., Chan, E., Luwor, R. B., Burns, C. J., Thompson, E. W., Findlay, J. K., & Ahmed, N. (2015) · Journal of Cancer Stem Cell Research · doi:10.14343/jcscr.2015.3e1001 · Cited by 7 · see citing works
Nguyen, Y. N. D., Jeong, J. H., Sharma, N., Tran, N. K. C., Tran, H.-Y. P., Dang, D., Park, J. H., Byun, J. K., Ko, S. K., Nah, S.-Y., et al. (2024) · Free Radical Research · doi:10.1080/10715762.2024.2341885 · Cited by 5 · see citing works
Guo, B., Wang, K., Wu, J., Yu, H., Geng, C., Jin, Y., & Song, Y. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114573 · Cited by 4 · see citing works
MiRNA affects the advancement of breast cancer by modulating the immune system's response
Fu, Y., Yang, Q., Xu, N., & Zhang, X. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167759 · Cited by 4 · see citing works
Tanabe, K., Inagaki, A., Henmi, Y., & Satake, M. (2018) · SLAS DISCOVERY · doi:10.1177/2472555217751091 · Cited by 4 · see citing works
Ansari, F. J., Behroozi, J., Chamanara, M., Shahrezaee, M., Shakerimoghaddam, A., Mousavi, S. H., Amanzadeh, A., Shokrgozar, M. A., Tafti, S. H. A., Ghorbani, M., et al. (2026) · Drug Delivery and Translational Research · doi:10.1007/s13346-026-02143-4 · Cited by 3 · see citing works
Lu, R., Zhao, R., Lian, P., Chen, G., Wang, R., Wazir, J., Ma, B., Gu, C., Pu, W., Li, L., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158267 · Cited by 3 · see citing works
Chu, H., Liu, S., Zhang, S., Wang, S., Hong-sheng, C., & Li, L. (2024) · Chinese Journal of Analytical Chemistry · doi:10.1016/j.cjac.2024.100397 · Cited by 3 · see citing works
Wang, H., & Wang, J. (2022) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v21i6.6 · Cited by 3 · see citing works
Peng, M., Meng, H., Wang, J., Guo, M., Li, T., Qian, X., Chen, R., Jin, H., & Huang, C. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18577 · Cited by 2 · see citing works
Peng, X., Wang, Y., Chen, Y., Hu, Y., Wu, F., Zhang, P., Xu, W., & Wei, Y. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s530776 · Cited by 1 · see citing works
Chung, W., Huang, W., Liao, W., Huang, W., Liu, Y., & Su, W. (2021) · Cancer Medicine · doi:10.1002/cam4.3824 · Cited by 1 · see citing works
Self-citationCong, Y., Cui, Y., Zhu, S., Cao, J., Qiao, G., Zou, H., Jiang, W. G., & Yu, Z. (2020) · doi:10.21203/rs.2.22315/v2 · Cited by 1 · see citing works
IL-6 as a Potential Biomarker in Lung Cancer
Yeh, Y., & Su, W. (2014) · Lung Cancer Management · doi:10.2217/lmt.14.14
Self-citationIL6 Gene Polymorphism and Oral Cancer: A Review
Zafar, M., Hadi, N., & Baig, S. (2024) · DOAJ (DOAJ: Directory of Open Access Journals)
Clay, T. D. (2017) · Minerva Access (University of Melbourne)
Cong, Y., Cui, Y., Zhu, S., Cao, J., Qiao, G., Zou, H., Jiang, W. G., & Yu, Z. (2020) · doi:10.21203/rs.2.22315/v1
Repair of Oxidative Damage in the Endometrial Epithelial Cells of Dairy Cows by Bad-MscsPreprint
Lu, W., Wang, Z., Si, L., Jin, J., Fu, S., & Cheng, X. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4902687
Chen, P.-C., Chang, Y.-C., Ho, Y.-Y., Tseng, K.-Y., Lin, K.-H., Sarı, S., ÖZDEMİR, Z., Reynisson, J., Leung, E., & Cheung, C. H. A. (2026) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2026.107605
- Authors
- Huang, W.-L., Yeh, H.-H., Lin, C.-C., Lai, W.-W., Chang, J.-Y., Chang, W.-T., & Su, W.-C.
- Affiliations
- National Cheng Kung University (TW)
- National Cheng Kung University Hospital (TW)
- National Health Research Institutes (TW)
- Corresponding author
- Su, Wu-Chou
- Venue
- Molecular Cancer
- Published
- 2010-12
- Volume
- 9
- Issue
- 1
- Pages
- 309-309
- ISSN
- 1476-4598 (ISSN-L)
- PMC
- PMC3027602
- OpenAlex
- W2170027004
- Cited by
- 86
- References
- 55
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 9 · 2023: 4 · 2022: 3 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 6 · 2016: 4 · 2015: 5 · 2014: 9 · 2013: 10 · 2012: 3
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Molecular Cancer (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science Council (DOH99-TD-C-111-003, NSC99-2120-M-006-005)
- National Health Research Institutes
- National Cheng Kung University
- Topics
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- STAT3, JAK2/STAT3 signaling, interleukin-6, lung adenocarcinoma, paclitaxel resistance, MEK/ERK signaling, PI3K/Akt signaling, NF-κB, positive feedback loop, drug resistance, tumor progression
- MeSH terms
- Adenocarcinoma of Lung, Adenocarcinoma, Enzyme-Linked Immunosorbent Assay, Humans, Lung Neoplasms, Neoplasms, Tumor Cells, Cultured, Blotting, Western, Signal Transduction, Interleukin-6, Paclitaxel, Drug Resistance, Neoplasm, Reverse Transcriptase Polymerase Chain Reaction, RNA Interference, Cell Line, Tumor, STAT3 Transcription Factor, Janus Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review